Vanda Pharmaceuticals
VNDA
#7652
Rank
ยฃ0.22 B
Marketcap
ยฃ3.81
Share price
3.24%
Change (1 day)
25.37%
Change (1 year)

Revenue for Vanda Pharmaceuticals (VNDA)

Revenue in 2024 (TTM): ยฃ0.14 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ0.15 Billion. In 2023 the company made a revenue of ยฃ0.15 Billion a decrease over the revenue in the year 2022 that were of ยฃ0.21 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Vanda Pharmaceuticals from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.14 B-1.71%
2023 ยฃ0.15 B-28.09%
2022 ยฃ0.21 B5.64%
2021 ยฃ0.19 B9.33%
2020 ยฃ0.18 B5.09%
2019 ยฃ0.17 B13.88%
2018 ยฃ0.15 B24.55%
2017 ยฃ0.12 B3.22%
2016 ยฃ0.11 B59.53%
2015 ยฃ74.17 M130.26%
2014 ยฃ32.21 M56.85%
2013 ยฃ20.53 M1.44%
2012 ยฃ20.24 M0.64%
2011 ยฃ20.11 M-13.03%
2010 ยฃ23.13 M723.09%
2009 ยฃ2.81 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ39.75 B 26,066.05%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ32.52 B 21,310.32%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ69.80 B 45,848.30%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ37.75 B 24,753.56%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ47.85 B 31,395.14%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ50.28 B 33,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA